ask="17.98"
ask_size="100"
average_daily_volume="65806"
bid="14.50"
bid_size="1000"
book_value="6.38"
change="-0.31"
change_from_200_day_moving_average="1.47"
change_from_50_day_moving_average="0.43"
change_from_52_week_high="-2.90"
change_From_52_week_low="4.78"
change_in_percent="-1.71%"
close="17.84"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-8.72"
ebitda="-48.18M"
eps_estimate_current_year="-4.11"
eps_estimate_next_quarter="-0.77"
eps_estimate_next_year="-3.46"
ex_dividend_date="N/A"
float_shares="6846000"
high="18.20"
high_52_weeks="20.74"
last_trade_date="1/11/2017"
last_trade_price="17.84"
last_trade_size="100"
last_trade_time="4:00pm"
low="17.24"
low_52_weeks="13.06"
market_capitalization="387.57M"
moving_average_200_day="16.37"
moving_average_50_day="17.41"
name="Audentes Therapeutics
Inc."
notes="N/A"
one_year_target_price="22.33"
open="18.17"
pe_ratio="N/A"
peg_ratio="-1.69"
percent_change_from_200_day_moving_average="+8.96%"
percent_change_from_50_day_moving_average="+2.48%"
percent_change_from_52_week_high="-13.98%"
percent_change_from_52_week_low="+36.60%"
previous_close="18.15"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.85"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21725000"
short_ratio="7.16"
stock_exchange="NGM"
symbol="BOLD"
volume="59209"
weeks_range_52="13.06 - 20.74"
